PerkinElmer (NYSE:PKI), a provider of life sciences tools and services, is launching a new Personalized Health Innovation Center of Excellence at an existing facility in Hopkinton, Mass. The creation of the center will add 100 workers to the Hopkinton operation, to a total of 350, through both new hires and relocating some existing personnel from other facilities. The Center will focus on accelerating scientific discoveries to help biotechnology researchers working on both personalized medicine drugs and diagnostic tools that help determine which patients will benefit most from which drugs. The center will be fully up and running before the end of the year, PerkinElmer executives said. The Hopkinton facility was previously the headquarters of Caliper Life Sciences, which was acquired by PerkinElmer last year for $600 million. The facility now houses the headquarters for the PerkinElmer Life Sciences and Technology business. We are delighted to establish our new Center of Excellence, which will serve as an exciting example of PerkinElmers commitment to, and culture of, innovation, Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, said. It will act as a foundation and catalyst for future advances in personalized health, as it concentrates the knowledge of our life sciences R&D and commercial leaders for greater scientific collaboration.

The center will bring together researchers from several teams including chemistry, biochemistry, cell biology, molecular biology and reagent development.

Read the original post:
PerkinElmer to open new Personalized Medicine Center

Comments are closed.